Two recent events suggest that the “Wild West Period” for ICOs may be drawing to a close. Recent statements by SEC Chairman, Jay Clayton, strongly suggest more SEC action to come and the first class-action suit related to an ICO has been filed.
Click here to read Dror Futter's analysis.
Mr. Futter has more than 20 years of
In this webinar, Rimon Partner Marc Kaufman and Questel Sales Director Austin Englert will discuss new techniques and tools for identifying and addressing intellectual property (IP) risk. You will learn how to identify potential hazards, convey them to business leaders, and develop strategies to achieve business goals while minimizing
The SEC has issued its first, much anticipated statement on the regulatory status of ICOs (Initial Coin Offerings).
Click here to read our analysis of the questions the SEC answered and, perhaps more importantly, the questions that remain unresolved.
Mr. Futter has more than 20 years of high tech and business experience. He
As technology reshapes the way we live and work, trade secrets have become very important. They have unleashed an unprecedented boom in litigation, legislation and media attention. And some investors and companies have found themselves in court or facing damages in the hundreds of millions of dollars.
“Trade secrets are the hardest
Partner Dror Futter will be a panelist on an ABA webinar discussing the different issues that arise when start-up companies become suppliers to larger, more established companies, and how to improve the likelihood of success for those relationships.
This presentation will address ways in which established companies can mitigate risks when
Continuing to expand and strengthen its international corporate presence, Rimon Law has added Chris Terry, a corporate transactional attorney with almost two decades of experience serving as a trusted advisor to multinationals, start-ups and venture funds, as a Partner in the firm’s San Francisco office.
Join Rimon's Paul Economon on Tuesday September 23, 2014 as he shares his insight on the protection of intellectual property in the early stages of an entreprenureal venture.
AccelerateDC is kicking off a Boost Your Startup speaker series this month with a panel discussion on how to protect every entrepreneurs’
So how do biotech ventures govern themselves to run efficiently while complying with state corporate law statutes and state and federal securities laws and regulations imposed by stock exchanges? Frugality that is often self-imposed by scientific founders and then endorsed by the angel investors and venture capital company investors that follow
The public securities markets and the underwriters that lead biotech companies into them dictate a common capital structure suitable for IPOs, which structure almost always deviates starkly from the capital structure of the venture at inception and during its growth phase. Startups frequently commence corporate life structured as limited liability